solid tumors
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
solid tumors
Jul 24, 2024, 14:57 |
Blog
Peter Lebowitz: Third Arc Bio is launching with the closing of $165 million Series A financing
Peter Lebowitz, CEO of Third Arc Bio, shared a post on Linkedin: "Today marks a…
Jul 22, 2024, 23:08 |
Blog
Hung Trinh: TOP CAR with TMIGD2 as a safe and effective domain treating human solid tumors
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Jul 20, 2024, 11:44 |
Blog
Sumanta K. Pal: A terrific review on ADCs in solid tumors led by Salvador Jaime-Casas
Sumanta K. Pal shared on X: "A terrific review on ADCs in solid tumors led…
Jul 17, 2024, 21:50 |
Blog
Kimryn Rathmell: New cellular immunotherapy may be effective in treating metastatic solid tumors
Kimryn Rathmell shared a post on X: ''Hot off the press from Steven Rosenberg and…
Jul 17, 2024, 21:49 |
Blog
Daily oral zelenirstat for advanced solid tumors and R/R B-cell lymphomas
Naveen Pemmaraju shared on X: ''A first-in-human phase I trial of daily oral zelenirstat, a…
Jul 17, 2024, 02:26 |
Insight
Patrick Hwu: When patients with solid tumors don’t respond to immunotherapy
Patrick Hwu shared a post on X about a recent paper by Maria Parkhurst et…
Jul 10, 2024, 07:24 |
Drugs
How well sotorasib with or without panitumumab can treat patients with advanced Solid Tumors - ECOG-ACRIN Cancer Research Group
ECOG-ACRIN Cancer Research Group shared on X: "ComboMATCH/EAY191-E5 tests how well sotorasib with or without…
Jul 10, 2024, 06:36 |
Insight
Paolo Tarantino: Intersecting data with the MAT2A inhibitor IDE397 in MTAPdel lung and urothelial cancer
Paolo Tarantino shared a post by Bio Stocks on X, adding: . "Intersecting data with…
Jul 7, 2024, 17:41 |
Blog
Miguel Bronchud: The importance of well-designed Randomized Controlled Trials
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared a post on LinkedIn: “I am not…
Jul 2, 2024, 10:50 |
Insight
The path to leptomeningeal metastasis
Jean-Charles Soria shared a post on LinkedIn: . "Leptomeningeal metastasis occurs in 5-10% of patients…
Jun 27, 2024, 12:32 |
Insight
Michael Klichinsky: Carisma Therapeutics received FDA Fast Track Designation for CT-0525
Michael Klichinsky, Co-Founder and Chief Scientific Officer at Carisma Therapeutics, shared on LinkedIn: “We are…
Jun 18, 2024, 02:59 |
Blog
Estela Rodriguez: Another tumor - agnostic approval
Estela Rodriguez shared a post on X: "Another tumor-agnostic approval. FDA Oncology grants accelerated approval…
Jun 16, 2024, 13:37 |
Drugs
Stephen Liu: FDA approves repotrectinib for NTRK fusion positive solid tumors
Stephen Liu recently shared a post on X: “FDA approves repotrectinib for NTRK fusion positive…
Jun 14, 2024, 15:26 |
Blog
Best practices in treating patients with solid-tumor and malignant hematology - Roswell Park
Roswell Park made the following post on X: Join us for the inaugural Upstate NY…
Jun 13, 2024, 07:54 |
Blog
Connect to the ESMO Virtual Plenary to stay up to date with the latest in immunotherapy
ESMO shared on LinkedIn: "What are the early safety and activity profiles of a first-in-class PD-1/IL-2…
Jun 13, 2024, 05:48 |
Blog
Rabab Hunaid Abbas: An exclusive keynote event with Dr. Thomas Marron
Rabab Hunaid Abbas, Member at Georgian International Medical Student Society, shared a post on LinkedIn: "Upcoming…
Jun 8, 2024, 11:07 |
Insight
Novel targeted cancer therapies demonstrate activity and safety in metastatic solid tumors
MD Anderson researchers share preliminary clinical data of an antibody-drug conjugate for metastatic colorectal cancer…
Jun 7, 2024, 16:55 |
Career
Sunil Verma: Day 1 in AstraZeneca as SVP, Global Head, Oncology Franchise
Sunil Verma shared on X: . "Day 1 in the…
Jun 5, 2024, 10:12 |
Societies
Samin Saeed: My first time at ASCO
Samin Saeed, Chief Medical Officer at Random42 Scientific Communication, shared a post on LinkedIn: "At…
Jun 1, 2024, 12:11 |
Societies
Carlos Torrado: Excited to present our poster at ASCO24
Carlos Torrado, Clinical Fellow at MD Anderson Cancer Center, recently shared a post by NCI…
May 22, 2024, 08:39 |
Blog
Tanja Obradovic: ASCO just published guidelines for germline genetic testing panels
Tanja Obradovic shared on LinkedIn: "Great service to public and oncology community as ASCO just published…
May 21, 2024, 04:43 |
Blog
Clinical and Translational Oncology PhD Programme participant Alaa Embaby's theses
The Clinical and Translational Oncology PhD Programme shared on LinkedIn: "On Tuesday May 21st, our…
May 16, 2024, 08:20 |
Blog
Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise
Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise Cash runway…
May 14, 2024, 15:00 |
Drugs
Ravi Karra discusses overcoming challenges in early phase drug development for solid tumors - Advanced Clinical
Advanced Clinical shared on LinkedIn: . "Innovative trial designs and advanced imaging modalities could address…
May 9, 2024, 00:21 |
Blog
Enes Erul: Trastuzumab deruxtecan shows promise in HER2-mutant solid tumors
Enes Erul, Oncology Fellow at Ankara Üniversitesi, shared on X: “Trastuzumab deruxtecan shows promise in HER2-mutant…
Apr 26, 2024, 20:41 |
Insight
Piotr Wysocki: CAR-T therapy seems to be associated with second primary malignant neoplasms
Piotr Wysocki recently shared on LinkedIn: "In a research letter published online in JAMA Oncology,…
Apr 26, 2024, 17:55 |
Insight
Piotr Wysocki: NECTIN4 amplification is a predictive factor for enfortumab vedotin efficacy
Piotr Wysocki recently shared on LinkedIn: "Kluemper et al. published results of a study evaluating NECTIN4…
Apr 26, 2024, 07:37 |
Blog
Meet the Author Amin H. Nassar by Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer shared on X/Twitter: "Meet the Author: Amin H. Nassar, a medical…
Apr 21, 2024, 23:34 |
Blog
Svetlana Nikic: Comprehensive and structured list of FDA-approved CDx NGS assays. Super easy to be found at FDA's website
Svetlana Nikic, Founder of Precision Oncology Consulting, shared a post on LinkedIn: "With an overwhelming amount…
Apr 21, 2024, 11:35 |
Insight
Samuel Kareff: Our pan-tumor analysis on the not-so-elusive HRAS mutation in solid tumors
Samuel Kareff, Hematology/Oncology Chief Fellow at the University of Miami Sylvester Comprehensive Cancer Center, shared…
Apr 20, 2024, 08:16 |
Blog
Tanja Obradovic: One exciting novel approach is just about to enter clinical development
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc, shared a post on LinkedIn: "Cell…
Apr 20, 2024, 07:47 |
Drugs
Paper summary by Marco Donia
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…
Apr 19, 2024, 05:17 |
Insight
Dina Schneider: Excited about our recent publication on Armored TGFBRIIdn ROR1-targeting CAR T cells for solid tumors
Dina Schneider, Director of Immuno Oncology and Cell Therapy at Lentigen Technology, shared on LinkedIn:…
Apr 18, 2024, 13:05 |
Blog
MD Anderson and CureVac have launched a strategic collaboration to develop off-the-shelf mRNA-based cancer vaccines
MD Anderson Cancer Center shared a post on LinkedIn: "MD Anderson and CureVac have launched a…
Apr 17, 2024, 00:52 |
Insight
UHN Research - Can a blood sample be used to predict patient outcomes to cancer immunotherapy drug pembrolizumab?
UHN Research shared on their LinkedIn: "Can a blood sample be used to predict patient…
Apr 16, 2024, 13:31 |
Blog
Sarabjot Pabla: What an incredible opportunity it was to be part of AACR2024
Sarabjot Pabla, Head of Clinical and Research Bioinformatics at OmniSeq, shared on their LinkedIn: ''What…
Apr 12, 2024, 09:45 |
Blog
Estela Rodriguez: Proud to work with LUNGevity Foundation and team to develop a discussion guide for biomarker testing for patients with solid tumors in plain language
Estela Rodriguez shared on X/Twitter: "Proud to work with LUNGevity Foundation and team to develop a discussion…
Apr 8, 2024, 16:01 |
Drugs
Rahul Gosain: Trastuzumab Deruxtecan now is FDA approved, Based on DESTINY-PanTumor02, DESTINY-Lung01, and DESTINY-CRC02
Rahul Gosain, Co-Founder of Oncology Brothers podcast and Director of Regional Infusion Services and Medical…
Apr 8, 2024, 15:41 |
Drugs
Tom Powles: This seems an ambitious accelerated approval in UC
Tom Powles, Director of Barts Cancer Center, recently shared on X: "TDXD received FDA accelerated…
Apr 8, 2024, 15:17 |
Blog
Petros Grivas: Can’t wait to join Paolo Tarantino and Helena Yu to review ADCs across solid tumors
Petros Grivas, Associate Professor at the University of Washington, recently shared a post by Paolo…
Apr 8, 2024, 13:02 |
Blog
Eric K. Singhi: Proud to work with LUNGevity Foundation and team to develop a discussion guide for biomarker testing for patients with solid tumors
Eric K. Singhi, Thoracic Medical Oncologist and Assistant Professor at the MD Anderson Cancer Center, recently…
Apr 7, 2024, 07:20 |
Insight
Wafik El-Deiry: Dr. Alice Shaw speaks about directions in ADC’s in cancer therapy at AACR 2024
Wafik El-Deiry, Director of the Legorreta Cancer Center at Brown University, recently posted on LinkedIn:…
Mar 29, 2024, 05:47 |
Blog
Nitin Jain: Fantastic talk by Dr Hind Rafei on current status of NK cell therapy
Katy Rezvani Chief of Section of Cellular Therapy, Department of Stem Cell Transplantation and Cellular…
Feb 23, 2024, 17:44 |
Drugs
Allison Betof Warner: The TIL team at Stanford Cancer Institute did our first surgical tumor harvest for AMTAGVI (lifileucel) this morning!
Allison Betof Warner, Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford…
Feb 23, 2024, 10:51 |
Blog
Amer Zeidan: Just an unbelievable cascade of news for magrolimab
Amer Zeidan shared on X: "Just an unbelievable cascade of news for magrolimab … Gilead…
Feb 19, 2024, 18:12 |
Career
Giles Robinson: Congratulations Sara Federico on being named the director of the Solid Tumor Division at the St. Jude Children’s Research Hospital
Giles Robinson, Neuro-Oncology Division Director at the St. Jude Children’s Research Hospital, shared on X/Twitter:…
Feb 19, 2024, 04:12 |
Dialogues
OncoDaily Walk and Talk with Maite Gorostegui, Hosted by Tatev Margaryan
Welcome back to Walk & Talk on OncoDaily! Our guest for today is Dr. Maite…
Jan 22, 2024, 09:50 |
Blog
Wei Zhang: Glad to see IGFBP2 as the top plasma marker for early cancer detection of 18 types of solid tumors
Wei Zhang, Director of Cancer Genomics and Precision Oncology, shared on LinkedIn: ''Early Cancer Detection…
Jan 7, 2024, 09:31 |
Blog
Kunal Desai: I’ll be joining AbbVie as Medical Director in their late-stage solid tumors clinical development team
Kunal Desai, Oncology Fellow at University of Chicago, shared a post on X/Twitter: "Now is a…
Dec 25, 2023, 16:45 |
Insight
Vivek Subbiah: Pleased to share the work of our amazing RET precision medicine team as we review
Vivek Subbiah shared on LinkedIn: "Hot off the press! Pleased to share the work of…
Dec 23, 2023, 04:00 |
Insight
Vivek Subbiah: Such a delight to share our non-human primate publication as a pre-cursor to our First-in-human phase 1 trial
Vivek Subbiah shared on X/Twitter: ''Such a delight to share our non-human primate publication on First-in-cynomolgus…
Dec 8, 2023, 17:50 |
Drugs
Pure Biologics to test molecule PBA-0405 in project PB004 in a Phase 0 clinical trial in patients with solid tumors - The Antibody Society
The Antibody Society shared on their LinkedIn page: "In an unusual (to us anyway) move,…
Oct 23, 2023, 13:31 |
Drugs
At ESMO 2023 Dr. Breelyn Wilky presented new data from our investigational botensilimab/balstilimab combination in relapsed/refractory sarcoma
Agenus shared on their LinkedIn page: "At ESMO 2023 Dr. Breelyn Wilky presented new data from our investigational…
All:
53
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube